SEAN GREEN: Open Payments
NPI 1679585517 · CANYON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 16 payments from 12 companies in 2025. Trend: 2023 $234 · 2024 $246 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $38 |
| Lilly USA, LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $28 |
| Astellas Pharma US Inc | 1 | $23 |
| Amgen Inc. | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: RS-4i Plus with Intersperse, MOUNJARO, TRELEGY ELLIPTA, Veozah, FARXIGA, OTEZLA, Leqembi, Wegovy.
Industry payments across TX — which companies pay providers there.
